American Cancer Society. (2015, June 10). Breast Cancer. Extrait de: http://www.cancer.org/cancer/breastcancer/index.
Brackstone M, Fletcher GG, Dayes IS, Madarnas Y, SenGupta SK, Verma S, and Members of the Breast Cancer Disease Site Group. Locoregional therapy of locally advanced breast cancer: a clinical practice guideline. (2015, March). Current Oncology. 22(S1): S54-S66.
Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. (2014, July). Journal of Clinical Oncology. 32(21): 2255-2270.
Goss, PE, Ingle JN, Pritchard KJ, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. (2016, July 21). New England Journal of Medicine. 175(3): 209-219.
Joy AA, Ghosh M, Fernandes R, Clemons MJ. Systemic treatment approaches in HER2-negative advanced breast cancer - guidance on the guidelines. (2015, March). Current Oncology. 22(S!): S29-S42.
Morrow M, Burstein HJ, and Harris JR. Malignant tumors of the breast. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 79: 1117-1156.
National Cancer Institute. (2015, July 8). Breast Cancer Treatment for Health Professionals (PDQ®).
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 2.2015). Extrait de: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.×